Levetiracetam Tablet, Film Coated
Product Images NDC 50090-7333

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 50090-7333). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

Bar chart depicting the percentage of patients across three groups: Placebo (7.4%), Levetiracetam Tablet 1000 mg/day (37.1%), and Levetiracetam Tablet 3000 mg/day (39.6%). The vertical axis shows the percentage of patients from 0% to 45%, and each group includes its sample size (N).*

FDA Label Image

Figure2 (Figure2)

A bar chart comparing the percentage of patients in three groups: Placebo with 6.3%, Levetiracetam Tablet 1000 mg/day with 20.8%, and Levetiracetam Tablet 3000 mg/day with 35.2%. The vertical axis is labeled '% of Patients.' Numbers of patients per group are provided below each bar.*

FDA Label Image

Figure3 (Figure3)

A bar graph comparing the percentage of patients between a placebo group and a Levetiracetam 3000 mg/day group. The y-axis represents the percentage of patients, ranging from 0% to 45%. The placebo group (N=104) shows 14.4%, while the Levetiracetam group (N=180) shows 39.4%.*

FDA Label Image

Figure4 (Figure4)

A bar graph comparing the percentage of patients between two groups: Placebo (N=97) and Levetiracetam Tablet (N=101). The y-axis represents the percentage of patients from 0% to 45%. The Placebo group shows 19.6%, while the Levetiracetam Tablet group shows 44.6%. An asterisk is present above the Levetiracetam bar, indicating statistical significance.*

FDA Label Image

Figure5 (Figure5)

A bar chart comparing the percentage of patients in two groups: Placebo (N=51) with 19.6%, and Levetiracetam (N=58) with 43.1%. The y-axis represents the percentage of patients, and the x-axis shows the two groups.*

FDA Label Image

Figure6 (Figure6)

Bar chart comparing the percentage of patients between placebo and Levetiracetam groups. The placebo group (N=84) shows 45.2%, while the Levetiracetam group (N=79) shows 72.2%. The y-axis is labeled as percentage of patients, ranging from 0% to 100%.*

FDA Label Image

Label Image (Lbl500907333)

Label for Levetiracetam 1000 mg film-coated tablets from A-S Medication Solutions. The label indicates a package containing 60 tablets, with a storage instruction to keep at 77 degrees Fahrenheit. It includes an NDC number 50090-7333 and a QR code linking to dosage information.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Levetiracetam, showing the molecular arrangement with a pyrrolidone ring and attached functional groups, consistent with the generic medication Levetiracetam.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.